Lipo-C Injection vs Retatrutide
A side-by-side research comparison of Lipo-C Injection and Retatrutide across mechanism, dosing, half-life, benefits, side effects and research status.
Comparison table
| Attribute | Lipo-C Injection | Retatrutide |
|---|---|---|
| Full name | Lipotropic MIC + B12 Injection | Retatrutide (Triple Agonist GIP/GLP-1/Glucagon) |
| Category | Weight Management | Weight Management |
| Status | Compounded medication | Phase 3 Clinical Trial |
| Mechanism | Methionine provides sulfur for detoxification, inositol supports fat transport from liver, choline emulsifies cholesterol and fat, B12 boosts cellular energy metabolism and red blood cell production. | Triple agonism creates synergistic metabolic effects. Glucagon activation increases energy expenditure and hepatic fat oxidation while GLP-1/GIP reduce appetite and improve insulin sensitivity. |
| Molecular weight | Combination compound | 5,200 Da (approximate) |
| Half-life | Variable by component | 6 days |
| Bioavailability | ~100% IM injection | High (SubQ) |
| Typical dose | 1 mL | 1-2 mg → titrate up to 12 mg |
| Frequency | 1-2x per week | Once weekly |
| Route | Intramuscular or subcutaneous injection | Subcutaneous injection |
Lipo-C Injection reported benefits
- Enhanced fat metabolism
- Liver support
- Increased energy
- B12 optimization
- Complements weight loss protocols
Retatrutide reported benefits
- Unprecedented weight loss (~24%)
- Significant liver fat reduction
- Improved cardiovascular markers
- Enhanced energy expenditure
- Superior glycemic control
Related comparisons
Research and educational reference only. Not medical advice.